Hepatotoxic action of CHCl
3 was examined biochemically by comparing with those of CCl
4 and other related halogenomethanes using normal and phenobarbital (PB)-pretreated animals. In the later stage (24 hr), in mice, PB pretreatment augmented CHCl
3-induced liver damage as evidenced by an enhancement of elevation of plasma transaminase activities and a parallel rise in liver triglyceride content. In the earlier stage (1 hr), in normal rats, CCl
4 (1.0 ml/kg, i.p.) decreased microsomal glucose-6-phosphatase (G-6-Pase) activity and cytochrome P-450 content, whereas no significant effect was observed with the same dose of CHCl
3. PB pretreatment produced a significant loss of both enzymes by CHCl
3, and enhanced the loss of cytochrome P-450 induced by CCl
4, while G-6-Pase activity was little affected by CCl
4 in PB-pretreated rats. Both hepatotoxins increased liver malondialdehyde (MDA) content. Some of these early changes in vivo were reproduced in the lipid peroxidation system in vitro. Diethyldithiocarbamate suppressed various toxic manifestations induced by CHCl
3 in PB-pretreated rats, but did not protect against the loss of cytochrome P-450 induced by CHCl
3 or CCl
4. These results suggest that lipid peroxidation hypothesis proposed for CCl
4 hepatotoxicity may be applied to the case of CHCl
3 though there exist some qualitatively different characteristics between these hepatotoxins, and that the mechanisms of the loss of microsomal G-6-Pase and cytochrome P-450 by either of these hepatotoxins might be different.
View full abstract